ANDA 62475, held by Fresenius Kabi USA. Doxycycline Hyclate.
As of Nov 16, 2026, ANDA 62475 (Doxy 100, Doxy 200), held by Fresenius Kabi USA, was first approved by FDA on Dec 9, 1983, with 16 approved supplements and 0 published complete response letters.
INDICATIONS & USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of Doxycycline for Injection, USP and other antibacterial drugs, Doxycycline for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 9, 1983 | Original application | Approved | None posted |
| Doxy 100EQ 100MG BASE/VIAL · injectable;injection | Doxycycline Hyclate | Rx |
| Doxy 200EQ 200MG BASE/VIAL · injectable;injection | Doxycycline Hyclate | Rx |
| Mar 31, 2025 | Supplement 61Labeling · Standard review | Approved | None posted |
| Apr 22, 2020 | Supplement 50Labeling · Standard review | Approved | None posted |
| Apr 22, 2020 | Supplement 49Labeling · Standard review | Approved | None posted |
| Jan 26, 2016 | Supplement 46Labeling · Standard review | Approved | None posted |
| Jan 26, 2016 | Supplement 45Labeling · Standard review | Approved | None posted |
| Jan 26, 2016 | Supplement 40Labeling · Standard review | Approved | None posted |
| Jan 28, 2014 | Supplement 38Labeling · Standard review | Approved | |
| Feb 27, 2008 | Supplement 32Labeling | Approved | None posted |
| Oct 17, 2005 | Supplement 22Labeling | Approved | None posted |
| Apr 2, 2003 | Supplement 19Labeling | Approved | None posted |
| Apr 2, 2003 | Supplement 16Labeling | Approved | None posted |
| Dec 5, 2002 | Supplement 17Manufacturing | Approved | None posted |
| May 8, 1996 | Supplement 12Manufacturing | Approved | None posted |
| Nov 8, 1994 | Supplement 10Manufacturing | Approved | None posted |
| Sep 3, 1992 | Supplement 11Labeling | Approved | None posted |
| Nov 3, 1988 | Supplement 9Manufacturing | Approved | None posted |
| Dec 9, 1983 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters